Welcome to our dedicated page for Universal Ins Hldgs SEC filings (Ticker: UVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Universal Insurance Holdings, Inc. (NYSE: UVE) SEC filings page provides access to the company’s regulatory disclosures as a U.S. property and casualty insurance holding company. Universal files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K with the Securities and Exchange Commission, covering its operations in personal residential homeowners lines of business and related insurance services.
Recent Form 8-K filings for Universal Insurance Holdings include announcements of quarterly financial results, share repurchase authorizations and cash dividends on common stock. Earnings-related 8-Ks incorporate press releases that present GAAP and non-GAAP financial measures, such as total revenues, net income available to common stockholders, core revenue, adjusted net income, diluted adjusted earnings per share, adjusted operating income, adjusted book value per share and adjusted return on common equity. These filings also summarize key underwriting metrics, including direct premiums written, net premiums earned, ceded premium ratio, loss ratio, expense ratio and combined ratio.
Other 8-K filings report Board actions authorizing multi-year share repurchase programs and declaring regular and special cash dividends. These documents describe the size and duration of repurchase authorizations, the intention to conduct repurchases in accordance with Rule 10b-18 under the Securities Exchange Act of 1934 and the company’s insider trading policy, and the per-share amounts of declared dividends.
On this page, Stock Titan pairs Universal’s SEC filings with AI-powered summaries that explain the main points of each document in plain language. Users can quickly see what Universal reported in its latest 10-K or 10-Q, how management describes non-GAAP financial measures and key performance indicators, and what material events are disclosed in 8-Ks. The filings feed updates as new documents are posted to EDGAR, helping investors follow Universal’s financial reporting, reinsurance-related disclosures and capital management decisions without reading every line of each filing.
Universal Insurance Holdings (UVE): Form 144 notice of proposed sale. A holder filed to sell 24,308 common shares, with an aggregate market value of $839,598.32. The filing lists Raymond James & Associates as broker and indicates an approximate sale date of 11/14/2025 on the NYSE.
The shares listed for sale were acquired in lieu of compensation on two dates: 7,298 shares on 01/13/2020 and 17,010 shares on 01/22/2018. As context, 28,286,229 shares were outstanding at the time shown in the notice; this is a baseline figure, not the amount being offered. The filing also reports a recent sale activity: Jon Springer sold 35,435 common shares on 10/30/2025 for $1,111,302.98.
Universal Insurance Holdings (UVE) received a Schedule 13G from Donald Smith & Co., Inc. reporting beneficial ownership of 1,494,895 common shares, equal to 5.28%.
Donald Smith & Co. reports sole voting power over 1,370,582 shares and sole dispositive power over 1,480,322 shares; DSCO Value Fund, L.P. holds 14,573 shares with sole voting and dispositive power. The filing states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control. The date of event which requires filing is 09/30/2025.
Universal Insurance Holdings (UVE) declared a cash dividend of $0.29 per share, consisting of a regular quarterly dividend of $0.16 and a special dividend of $0.13. The dividend is payable on December 12, 2025 to shareholders of record as of December 5, 2025.
This brings total regular and special dividends declared in 2025 to $0.77 per share. The mix of a recurring quarterly dividend plus a special payout signals an additional return to shareholders beyond the regular distribution for the year.
Universal Insurance Holdings (UVE): insider transaction reported. Executive Chairman and Director Sean P. Downes sold 20,000 shares of common stock on 10/29/2025 at a weighted average price of $31.4034. The sale occurred in multiple trades within a price range of $30.84 to $31.71.
Following this transaction, Downes beneficially owns 1,283,512 shares directly. He also reports indirect holdings of 18,000 shares by children and 2,000 shares by spouse.
Universal Insurance Holdings (UVE) — insider transaction filed. A company director reported a sale of common stock on 10/30/2025. The filing shows a disposition of 35,435 shares coded “S” for sale at a weighted average price of $31.4119.
Following the transaction, the reporting person beneficially owns 271,628 shares, held directly. The shares were sold in multiple trades within a price range of $31.13 to $31.625, and detailed trade‑by‑trade information is available upon request as noted in the footnote.
Universal Insurance Holdings (UVE) reported a profitable Q3 2025, with net income of $39.8 million after a loss in the prior year. Total revenues were $401.0 million as net premiums earned rose and losses and loss adjustment expenses fell to $252.3 million from $317.0 million a year ago. Diluted EPS was $1.38 (basic $1.43).
For the nine months, revenues reached $1.196 billion and net income was $116.4 million, reflecting stronger underwriting results and higher investment income. The balance sheet strengthened: stockholders’ equity increased to $495.0 million, cash and cash equivalents rose to $405.1 million, and restricted cash was $69.1 million. Unpaid losses declined to $682.6 million, aided by settlement of prior catastrophe claims. The company paid a $0.16 quarterly common dividend and continued share repurchases while maintaining $100.0 million of senior notes due 2026 and an undrawn $50.0 million revolving credit line. Shares outstanding were 28,048,881 as of October 27, 2025.
UVE filed a Form 144 notice for a proposed sale of 35,435 shares of common stock. The planned broker is Raymond James & Associates, and the filing lists an aggregate market value of $1,116,202.50. The approximate date of sale is 10/30/2025 on the NYSE.
The seller acquired these shares on 04/06/2018 in lieu of compensation from the issuer, with payment described as cash on the same date.
UVE filed a Form 144 notice for a proposed sale of 20,000 common shares with an aggregate market value $620,000, expected on 10/29/2025. The broker is Raymond James & Associates, and the shares are listed on the NYSE. Shares outstanding were 28,287,000.
The notice shows the securities to be sold were acquired on 03/13/2014 via Lieu Compensation from the issuer, with 110,309 shares acquired and cash listed as the nature of payment on that date.
Recent activity disclosed includes two sales of 20,000 shares each: on 08/04/2025 for $462,794.05 and on 09/04/2025 for $505,958.05.
Universal Insurance Holdings (UVE) furnished a press release announcing its financial results for the fiscal quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The information, including Exhibit 99.1, is being furnished to the SEC and shall not be deemed “filed” under the Exchange Act or incorporated by reference unless specifically stated. The Form 8-K was signed by CFO Frank C. Wilcox on October 23, 2025.
Sean P. Downes, Executive Chairman and Director of Universal Insurance Holdings, Inc. (UVE), reported an insider sale on 09/04/2025. He disposed of 20,000 shares of common stock in multiple transactions at a weighted-average price of $25.3482, with individual trade prices ranging from $25.07 to $25.55.
After the sale Mr. Downes directly holds 1,303,512 shares. He also reports indirect holdings of 18,000 shares through his children and 2,000 shares through his spouse, implying total reported beneficial ownership of 1,323,512 shares when combining direct and indirect holdings disclosed on this Form 4.